Keyphrases
Apoptosis
100%
Ischemia-reperfusion Injury
100%
Thrombopoietin
100%
Myocardial Infarct Size
100%
Janus Kinase 2 (JAK2)
27%
Ischemia
27%
Myocardial Ischemia-reperfusion
27%
KATP Channel
18%
Thrombopoietin Receptor
18%
Reperfusion
18%
Cardioprotection
18%
PD98059
18%
P44/42 Mitogen-activated Protein Kinase
18%
AG490
18%
5-HD
18%
Potential Therapeutics
9%
Mitogen-activated Protein Kinase
9%
Immunohistochemistry
9%
Rat Model
9%
Protective Behavior
9%
Myocardial Fibrosis
9%
Quantitative PCR
9%
Receptor-interacting Protein Kinase 1 (RIPK1)
9%
Optimal Dose
9%
Myocardial Ischemia
9%
Western Blotting
9%
Dose Effect
9%
Physiological Function
9%
Infarct Size
9%
Platelet Production
9%
Concentration-dependent
9%
Hematocrit
9%
Ventricular Function
9%
2-Arachidonoylglycerol (2-AG)
9%
Platelet Count
9%
Therapeutic Role
9%
Single Treatment
9%
Optimal Concentration
9%
Mitochondrial KATP Channel
9%
Induced Resistance
9%
C-Mpl
9%
Medicine and Dentistry
Myocardial Infarction
100%
Programmed Cell Death
100%
Ischemia
100%
Thrombopoietin
100%
Adenosine Triphosphate Sensitive Potassium Channel
27%
Heart Muscle Ischemia
27%
Janus Kinase 2
27%
In Vitro
18%
Heart Protection
18%
Injury
18%
2 (2 Amino 3 Methoxyphenyl)chromone
18%
Thrombopoietin Receptor
18%
Mitogen-Activated Protein Kinase
18%
Platelet
9%
Single Drug Dose
9%
Heart Ventricle Function
9%
Hematocrit
9%
Infarction
9%
Thrombocytopoiesis
9%
Receptor Protein
9%
Optimal Drug Dose
9%
Mitogen Activated Protein Kinase 3
9%
Heart Muscle Reperfusion
9%
Heart Muscle Necrosis
9%
Induced Resistance
9%
Reverse Transcription Polymerase Chain Reaction
9%
Immunohistochemistry
9%
Clamikalant
9%
Western Blotting
9%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
Ischemia
100%
Thrombopoietin
100%
Adenosine Triphosphate Sensitive Potassium Channel
27%
Heart Muscle Ischemia
27%
Janus Kinase 2
27%
Injury
18%
Mitogen Activated Protein Kinase
18%
2 (2 Amino 3 Methoxyphenyl)chromone
18%
Thrombopoietin Receptor
18%
Rat Model
9%
Western Blot
9%
Receptor Protein
9%
Mitogen Activated Protein Kinase 3
9%
Infarction
9%
Heart Muscle Necrosis
9%
Clamikalant
9%